Crop diseases caused by pathogens, viruses and fungi are very costly and can result in significant yield losses for farmers. Roger Innes, Distinguished Professor of biology at Indiana University Bloomington’s College of Arts and Sciences, has developed a method to enhance the immune system of plants to detect harmful pathogens in hopes of preventing these… Read more »
IU Innovation and Commercialization Office
Winners of IU Life Sciences to Healthcare Solutions Pitch Competition announced
Two Indiana University faculty-led teams were selected as winners of the inaugural IU Life Sciences to Healthcare Solutions Pitch Competition, hosted by IU Research and the IU Innovation and Commercialization Office. A future reality portal that enhances addiction recovery won first place, while an instrument that assesses corneal sensation in patients won second place. “This… Read more »
IU School of Medicine researcher determines PRMT5 inhibitors can help treat pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth deadliest cancer and has a five-year survival rate of only 10 percent. PDAC, which accounts for more than 90 percent of pancreatic cancer cases, is known to be resistant to most therapeutic agents, and often the diagnosis is late in disease progression as symptoms are difficult to identify…. Read more »
IUPUI researcher creates molecules with potential to treat COVID-19
Faculty and students at IUPUI are working on new ways to treat SARS-CoV-2, the virus causing COVID-19. Bill Scott, a research professor at the IUPUI School of Science, and his team have developed synthetic procedures to make numerous molecules to treat infections of both existing and mutated forms of SARS-CoV-2. The molecules created by Scott… Read more »
Moving IU innovation to market to improve Hoosier health
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed to the following story. In the last 30 years, Indiana University researcher Mark Kelley has disclosed 61 inventions, been awarded 19 patents, created a startup and licensed three of his technologies. He credits partnerships with IU’s Innovation and Commercialization Office (ICO) and… Read more »
IU School of Medicine researcher develops a novel, highly efficient method of producing retinal organoids
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Current treatment options for degenerative retinal diseases are only temporary fixes. Degeneration of the retina can lead to partial loss of vision or complete blindness; however, a team of Indiana University researchers have found a method of developing retinal… Read more »
IU School of Medicine researcher develops non-invasive tool to detect mutations that could potentially lead to breast cancer
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. A non-invasive diagnostic test to detect mutations that could lead to early-stage breast cancer has been developed by Indiana University researcher Harikrishna Nakshatri, Marian J. Morrison Professor of Breast Cancer Research and professor of surgery, biochemistry and molecular biology… Read more »
IU School of Medicine researchers find RAP minimizes nephrotoxicity and acute kidney injury
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Bruce Molitoris, MD, MS, a distinguished professor emeritus at the Indiana University School of Medicine and internationally acclaimed scientist, has determined that the Alpha-2-macroglubin Receptor Associated Protein, a naturally occurring protein inhibitor of kidney proximal tubule reabsorption, minimizes drug-induced… Read more »
IU researcher develops new therapy for treatment of ALS
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. Indiana University researcher Chandler Walker, Ph.D., has developed a new stem cell-based secretome therapy that influences both the central and peripheral components of Amyotrophic Lateral Sclerosis pathology. Secretome refers to the secretions of tissue or cells that can be… Read more »
IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. In the United States alone, Alzheimer’s disease currently affects 6.5 million people and over 11 million caregivers. National costs are projected to reach $1 trillion by 2050. Current early detection approaches for Alzheimer’s disease and other forms of cognitive… Read more »